Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,655 | -39,884 | -19,113 | -4,468 | -3,298 |
| Depreciation Amortization | 4,095 | 3,101 | 2,110 | 779 | 325 |
| Other Working Capital | -4,168 | 3,226 | 1,536 | -658 | 951 |
| Other Operating Activity | 10,209 | 3,422 | -1,705 | -2,464 | -1,195 |
| Operating Cash Flow | $-20,519 | $-30,135 | $-17,172 | $-6,811 | $-3,218 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,948 | -10,201 | -2,133 | -1,034 | -1,651 |
| Other Investing Activity | 38,814 | -13,381 | 10,285 | -76,604 | -1,138 |
| Investing Cash Flow | $31,866 | $-23,582 | $8,153 | $-77,638 | $-2,789 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -235 | 49,812 | -786 | 91,526 | 15,578 |
| Financing Cash Flow | $-235 | $49,812 | $-786 | $91,526 | $15,578 |
| Beginning Cash Position | 12,533 | 16,438 | 26,243 | 19,167 | 9,595 |
| End Cash Position | 23,646 | 12,533 | 16,438 | 26,243 | 19,167 |
| Net Cash Flow | $11,113 | $-3,905 | $-9,805 | $7,076 | $9,572 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,519 | -30,135 | -17,172 | -6,811 | -3,218 |
| Free Cash Flow | -20,519 | -30,135 | -17,172 | -6,811 | -3,218 |